`raynimrod@quinnemanuel.com; Brausa, Adam R.
`Matthew Traupman; Landon Smith; rweires@mofo.com; kiradavis@mofo.com; ddurie@mofo.com;
`paul@rmmslegal.com; jmarx@rmmslegal.com; nmclaughlin@rmmslegal.com; sbirkos@rmmslegal.com;
`dmazzochi@rmmslegal.com; tehrich@rmmslegal.com; lgreen@geminilaw.com; fchu@geminilaw.com; Trials
`IPR2023-00884
`Thursday, April 18, 2024 2:41:49 PM
`
`From:
`To:
`Cc:
`
`Subject:
`Date:
`
`Counsel,
`
`From the Board –
`
`It has come to the Board’s attention that the parties have yet to report to the Board recent
`developments, at both the district and appellate court levels, in the related district court litigation,
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 1:22-cv-00061 (ND WVa) (Paper
`2 at 9; Paper 3 at 2). At a conference call between the parties and Panel several months ago, the
`parties were instructed to update the Board with respect to this related matter. To this, the parties’
`response was that a public version of the Court’s final decision was expected and would be provided,
`and also that any decision would be expeditiously appealed (at least) with respect to the stipulated
`judgment in that Court as there were material disagreements on claim construction matters.
`
`The parties are instructed to provide the Board with an update. Provide a joint summary of the
`status of this related matter; file as an exhibit the decision of the District Court, if one has been
`entered deciding the validity of the patent challenged in this proceeding; and, if warranted, file
`updated mandatory notices, identifying what is updated.
`
`We note that Patent Owner’s exhibits in this proceeding (242 in total) have been filed without
`descriptive document names other than reiterating the exhibit number and whether the exhibit is
`confidential or redacted. This is not helpful to the Board and is not preferred. Any exhibit filed in
`this matter should include a very brief descriptive document name (Petitioner has done so) to aid
`the Board in navigating the record.
`
`Regards,
`
`Esther Goldschlager
`Supervisory Paralegal Specialist
`Patent Trial & Appeal Board
`U.S. Patent & Trademark Office
`
`Exhibit 3002
`
`